SMSF trustees should review suspended or delisted holdings before 30 June 2026. Realising these positions will crystallise capital losses (usable against future gains) and simplify fund portfolios ahead of the Division 296 reset.
SMSF trustees should review suspended or delisted holdings before 30 June 2026. Realising these positions will crystallise capital losses (usable against future gains) and simplify fund portfolios ahead of the Division 296 reset.
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
10 May 2026
| Name: | REPRODUCTIVE HEALTH SCIENCE LIMITED (RHS) (This company subsequently changed its name and is now RHS LIMITED. You should refer to that name for Status.) | ||||||||||||||||||
| Date of Listing: | 05 March 1987 | ||||||||||||||||||
| Subsequent Names: |
| ||||||||||||||||||
| Former Names: |
|
Stock Exchange Status:
This company subsequently changed its name and is now RHS LIMITED. You should refer to that name for Stock Exchange Status.Legal Status:
This company subsequently changed its name and is now RHS LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status:
This company subsequently changed its name and is now RHS LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| RHS LIMITED | 13/06/2017 | |
| REPRODUCTIVE HEALTH SCIENCE LIMITED | 22/04/2014 | 13/06/2017 |
| AO ENERGY LIMITED | 15/01/2013 | 22/04/2014 |
| AUSTRALIA ORIENTAL MINERALS NL | 09/02/2005 | 15/01/2013 |
| MARLBOROUGH RESOURCES NL | 08/12/1999 | 09/02/2005 |
| MARLBOROUGH GOLD MINES NL | 30/09/1994 | 08/12/1999 |
| MARLBOROUGH GOLD MINES LIMITED | 30/09/1994 |
REGISTRY:
MUFG Corporate Markets Limited (was Link Market Services)
Liberty Place Level 41 161 Castlereagh St Sydney NSW 2000
Locked Bag A14 Sydney South NSW 1235
Tel : 1300 554 474
Fax : (02) 9287 0303 or (02) 9287 0309 (for voting)
RegistryWebsite RegistryEmail
name changed to RHS Limited | 13/06/2017 |
The securities of Reproductive Health Science Limited will be reinstated to official quotation immediately, following the Company's announcement regarding completion of its capital raising. | 05/06/2017 |
The company has completed a placement of 10,714,285 shares to sophisticated investors at $0.14 per share through Taylor Collison Limited as lead broker. The capital raising of $1.5M will assist expansion of marketing and business development activities, particularly collaborations for commercial opportunities for DOPlifyTM including in liquid biopsy and non-invasive PGS. The $0.14 share price for the placement is an approximate 8.1% discount to the VWAP of the last 15 days on which trades occurred. | 05/06/2017 |
The securities of Reproductive Health Science Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement about a capital raising. | 02/06/2017 |
name changed from AO Energy Limited | 22/04/2014 |
name changed to RHS Limited | 13/06/2017 |
The securities of Reproductive Health Science Limited will be reinstated to official quotation immediately, following the Company's announcement regarding completion of its capital raising. | 05/06/2017 |
The company has completed a placement of 10,714,285 shares to sophisticated investors at $0.14 per share through Taylor Collison Limited as lead broker. The capital raising of $1.5M will assist expansion of marketing and business development activities, particularly collaborations for commercial opportunities for DOPlifyTM including in liquid biopsy and non-invasive PGS. The $0.14 share price for the placement is an approximate 8.1% discount to the VWAP of the last 15 days on which trades occurred. | 05/06/2017 |
The securities of Reproductive Health Science Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement about a capital raising. | 02/06/2017 |
name changed from AO Energy Limited | 22/04/2014 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 07/10/2016 | Sue MacLeman | 12,500 | $0.080 | $1,000 | |
| 15/10/2012 | Colin Goodall | On market | 16,900,000 | $0.003 | $51,146 |
| 15/10/2012 | David Bamford | On market | 3,000,000 | $0.003 | $9,005 |
| 12/10/2012 | Alexander Downer | On market | 1,000,000 | $0.003 | $3,000 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Ray Ridge | CFO, Company Secretary | 04/05/2015 |
| David Brooks | Non Exec Director | 22/11/2013 |
| Sue MacLeman | Non Exec Director | 21/08/2014 |
| Graham Ascough | Director | 31/07/2013 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Fabian Dwyer | Non Exec Director | 01/09/2015 | 21/04/2016 |
| Donald Stephens | Director | 31/07/2013 | 01/09/2015 |
| Simon O'Loughlin | Chairman | 12/04/2012 | 21/08/2014 |
| David McAuliffe | Non Exec Director | 16/08/2013 | 22/11/2013 |
| Colin Goodall | Chairman, Director | 18/07/2012 | 31/07/2013 |
| Neil Young | Managing Director | 18/07/2012 | 31/07/2013 |
| Jeremy Jebamoney | Executive Director | 03/10/2012 | 31/07/2013 |
| David Bamford | Non Exec Director | 03/10/2012 | 19/07/2013 |
| Alexander Downer | Director | 12/10/2012 | 19/07/2013 |
| Andrew Bursill | Director | 08/06/2010 | 03/10/2012 |
| Geoffrey Andrews | Non Exec Chairman, Director | 28/01/2009 | 18/07/2012 |
| Patrick Elliot | Chairman | 09/11/1998 | 25/05/2012 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2026 Investogain Pty Limited. All rights reserved.